ReviewJournal of hematology & oncology2017

Ongoing clinical trials of PD-1 and PD-L1 inhibitors for lung cancer in China.

Si-Yang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.